Here are relevant reports on : ivf-consumables-reagents-market
-
Cell Sorting Market by Technology (FACS-based Droplet Sorting, MACS, Microfluidics), Product (Cell Sorters, Reagents, Consumables), Application (Research, Clinical), End User (Research Institutes, Biopharma Companies, Medical Schools) - Forecasts to 2021
The global cell sorting market is projected to grow at a CAGR of 7.0%. Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of this market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. However, factors such as the high cost of instruments and lack of awareness & technical knowledge regarding the use of cell sorters are hampering the growth of this market.
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
NGS Sample Preparation Market by Product (Reagents & Consumables, Workstations), Workflow (Library Prep, Target Enrichment), Sample Type (DNA), Application (Diagnostics, Drug Discovery), Method (Microfluidic, Automated), End User & Region - Global Forecast to 2028
The global NGS sample preparation market in terms of revenue was estimated to be worth $1.9 billion in 2022 and is poised to reach $4.0 billion by 2028, growing at a CAGR of 13.4% from 2022 to 2028. The market for NGS sample preparation is highly consolidated, with key players strategizing to capture the market. Prominent players in the NGS sample preparation market are Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), PerkinElmer Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Danaher (US), Becton, Dickinson and Company (US), Merck KGAA (Germany), QIAGEN (Germany), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Eurofins Scientific (Luxembourg), BGI (China), 10x Genomics (US), Sysmex Corporation (US), Psomagen (US), Zymo Research Corporation (US), Takara Bio Inc. (Japan), Novogene Co., Ltd. (China), New England Biolabs (US), Tecan Trading AG (US), Oxford Nanopore Technologies PLC (UK), PacBio (US), Medgenome (US), and Swift Biosciences Inc. (US).
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Biopharmaceutical Cell Culture Market by Product [Consumables (Media, Sera, Reagents; Accessories), Equipment (Bioreactors, Centrifuges, Filters, Incubators, Freezers)], Type (mAbs, Vaccines, Other), End User (Biopharma, CMOs) - Global Forecast to 2031
The global biopharmaceutical cell culture market, valued at USD 11.63 billion in 2025, stood at USD 12.81 billion in 2026 and is projected to advance at a resilient CAGR of 13.8% from 2026 to 2031, culminating in a forecasted valuation of USD 24.47 billion by the end of the period. The report profiles key players, including Thermo Fisher Scientific (US), Danaher (US), Sartorius AG (Germany), Merck KGaA (Germany), Corning Incorporated (US), FUJIFILM Holdings Corporation (Japan), and Eppendorf SE (Germany).
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Germany Cell Culture Market by Product (Consumables (Media, Sera, Reagents, Vessels (Roller bottle, Flask, Cell Factory)), Equipment (Bioreactors, Centrifuges, Filtration, Incubators, Freezers)), Application (mAbs, Vaccines, CGT), End User - Forecast to 2031
The Germany cell culture market is projected to reach USD 4.86 billion by 2031, growing at a CAGR of 13.2% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
PCR Technologies Market by Technology (qPCR, dPCR, Multiplex, RT-PCR), Product (Instruments, Reagents & Consumables, Software), Application (Genotyping, Diagnostics, Environmental), End User (Hospital, Academia, Pharma-Biopharma) – Global forecast to 2031
The global PCR technologies market is projected to reach USD 21.43 billion by 2031, growing at a CAGR of 6.6% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Middle East Cell Culture Market by Product (Consumables (Media, Sera, Reagents, Vessels (Roller Bottle, Flask, Cell Factory)), Equipment (Bioreactors, Centrifuges, Filtration, Incubators, Freezers)), Application (mAbs, Vaccines, CGT), & End User - Forecast to 2031
The Middle East cell culture market, valued at USD 0.51 billion in 2025, stood at USD 0.54 billion in 2026 and is projected to advance at a resilient CAGR of 9.1% from 2026 to 2031, culminating in a forecasted valuation of USD 0.83 billion by the end of the period.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Human Identification Market by Product [Consumables (Kits & Reagents), Instruments, Software], Technology (PCR, Capillary Electrophoresis, NGS, Microarray, Rapid DNA Analysis), Application (Forensics, Paternity Testing), End User - Global Forecast to 2031
The global human identification market, valued at USD 0.89 billion in 2025, stood at USD 1.01 billion in 2026 and is projected to advance at a resilient CAGR of 10.9% from 2026 to 2031, culminating in a forecasted valuation of USD 1.69 billion by the end of the period. The key players include Thermo Fisher Scientific Inc. (US), QIAGEN N.V. (Netherlands), Promega Corporation (US), Hamilton Company (US), FUJIFILM Wako Pure Chemical Corporation (Japan), ANDE (US), AutoGen Inc. (US), InnoGenomics Technologies, LLC (US), Oxford Nanopore Technologies Plc (UK), Bode Cellmark Forensics Inc. (US), Carolina Biological Supply (US), Genetek Biopharma GmbH (Germany), STRmix Limited (New Zealand), Ningbo HEALTH Gene Technologies Co., Ltd. (China), and SoftGenetics (US).
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Immunochemistry Instruments & Reagents Market by Product [Analyzer (CLIA, IFA, ELA, RIA, & ELFA), Stainer, Incubator, Autoclave, Consumables (Antibodies, Enzymes, & Antigens)], Cardiology, Endocrinology, Oncology, Hospitals, & Labs –Forecast to 2019
The global immunochemistry instruments and reagents market is expected to reach $24.5 billion by 2019 from $17.3 billion in 2014, growing at a CAGR of 7.2% from 2014 to 2019. There is a rising focus on biomarker development across the globe as they help in detection of various diseases in their initial stage. Immunochemistry plays a crucial role in the development of biomarkers thus with the growing demand of biomarkers, the market for immunochemistry instruments and reagents will also flourish. Furthermore, government support in terms of funds and grants has also provided much needed impetus to this market. Moreover, increasing focus on drug monitoring and growing incidences of various diseases are other factors driving the growth of the market. In addition to this, technological advancements due to which automated and more accurate instruments are present in the market is another major factor propelling the growth of the market. However, factors such as stringent regulations for the development and launch of immunochemistry products and low adoption rate of automated immunochemistry products in developing economies due to high cost can hinder the growth of the market in coming years.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blot, Flow Cytometry, ELISA), Application (Proteomics, Genomics), End User (Pharma, Biotech, CROs) & Region - Global forecast to 2028
The global research antibodies & reagents market, valued at US$1.3 billion in 2022, stood at US$1.8 billion in 2023 and is projected to advance at a resilient CAGR of 45.6% from 2023 to 2028, culminating in a forecasted valuation of US$12.1 billion by the end of the period. The growth of this market is largely driven by an increase in research activity—especially in the life sciences industry—along with growing industry-academia collaborations are a primary growth driver for this market.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Cell Culture Reagents Market by Type (Growth Factors, Supplements, Cell Dissociation Reagents, Buffers & Chemicals, Others), Application (mAbs, Vaccines, CGT), End User (Pharma Biotech, Diagnostic Labs, Academia, Others), Region - Global Forecast to 2030
The cell culture reagents Market, valued at US$4.70 billion in 2024, stood at US$5.06 billion in 2025 and is projected to advance at a resilient CAGR of 12.1% from 2025 to 2030, culminating in a forecasted valuation of US$8.95 billion by the end of the period. The expansion of the global cell culture reagents market is primarily attributed to the global increase in biopharma manufacturing.
- Published: October 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
